Dr. Mona Bafadhel discusses the STOIC trial, which looked at the use of inhaled budesonide in the treatment of early COVID-19.

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00160-0/fulltext

Dr. Arvinder Soin discusses the use of tocilizumab plus standard care versus standard care alone in the treatment of moderate to severe COVID-19-associated cytokine release syndrome. 

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00081-3/fulltext

Jordan Feld discusses the use of peginterferon-lambda in the treatment of ambulatory COVID-19 patients.

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30566-X/fulltext

Rishi Gupta discusses a model to evaluate and predict the risk of clinical deterioration in patients with acute COVID-19.

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30559-2/fulltext

Toby Maher discusses the results of the SENSCIS trial, looking at the safety and efficacy of nintedanib in systemic sclerosis-associated interstitial lung disease (SSc-ILD) treated with mycophenolate.

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30458-6/fulltext

Dr. Catherine Quantin discusses a new study looking at the ways severe influenza and COVID-19 are similar and differ. 

Dan Lewer of University College London discusses a modelling study that looks at housing strategies for homeless populations in the UK during COVID-19.

Dr. Anna Schultze discusses inhaled corticosteroid use in COPD and asthma patients and whether they have either a protective or harmful effect when related to COVID-19

Richard Beasley discusses a Series of three papers in The Lancet and The Lancet Respiratory Medicine that consider the promise of novel strategies to drive down the global burden of asthma.

Dr. Reagan-Steiner and Dr. Gary about pathlogical findings in suspected cases of e-cigarette, or vaping, product use-associated lung injury, or EVALI.